Insider · CIK 0001750376
Jessi L Corcoran
Files at JBTM (John Bean Technologies CORP), MDLN (Medline Inc.). First filing Jun 9, 2026, latest Jun 9, 2026.
In brief
Jessi L Corcoran files SEC Form 4 as officer at MDLN (Medline Inc.), and also at JBTM (John Bean Technologies CORP). Since Jun 9, 2026, Jessi L Corcoran has reported 1 open-market buy worth $171k and 0 open-market sells worth $0, the latest filed on Jun 9, 2026.
A track record needs three past buys with six months of prices behind them; Jessi L Corcoran has 0, so none is measured yet.
The newest scored trade: bought $171k of MDLN on Jun 5, 2026, filed Jun 9, 2026, scored 52 (moderate). In the last 12 months: 1 buy worth $171k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDLN: Medline Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 52Moderate | MDLNbuy Medline Inc. | $171k 5,000 shares | - | +1% from low-33% from high |
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | MDLN Medline Inc. | POpen-market purchase Class A Common Stock | +5,000 | $34.15 | $171k | 5,000 | Jun 9, 2026 |
| Feb 26, 2025 | JBTM John Bean Technologies CORP | AGrant or award Common Stock | +786 | $0.00 | $0 | 3,302 | Feb 28, 2025 |
| Feb 26, 2025 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -256 | $117.24 | $30k | 3,046 | Feb 28, 2025 |
| Feb 26, 2025 | JBTM John Bean Technologies CORP | AGrant or award Common Stock | +721 | $0.00 | $0 | 3,767 | Feb 28, 2025 |
| Feb 27, 2025 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -63 | $131.35 | $8,275 | 3,704 | Feb 28, 2025 |
| Feb 24, 2025 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -133 | $117.24 | $16k | 2,585 | Feb 26, 2025 |
| Feb 24, 2025 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -69 | $117.24 | $8,090 | 2,516 | Feb 26, 2025 |
| Oct 16, 2024 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -44 | $98.41 | $4,330 | 2,718 | Oct 17, 2024 |
| Mar 8, 2024 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -99 | $104.11 | $10k | 2,869 | Mar 12, 2024 |
| Mar 8, 2024 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -107 | $104.11 | $11k | 2,762 | Mar 12, 2024 |
| Feb 27, 2024 | JBTM John Bean Technologies CORP | AGrant or award Common Stock | +307 | $0.00 | $0 | 2,330 | Feb 28, 2024 |
| Feb 27, 2024 | JBTM John Bean Technologies CORP | AGrant or award Common Stock | +638 | $0.00 | $0 | 2,968 | Feb 28, 2024 |
| Feb 22, 2024 | JBTM John Bean Technologies CORP | FTax withholding Common Stock | -69 | $99.85 | $6,890 | 2,023 | Feb 23, 2024 |
| Oct 16, 2023 | JBTM John Bean Technologies CORP | AGrant or award Common Stock | +147 | $0.00 | $0 | 2,092 | Oct 18, 2023 |
Questions about Jessi L Corcoran
Answered from the filings on this page, as of the latest one.
Is Jessi L Corcoran buying or selling?
In the last 12 months Jessi L Corcoran reported 1 open-market buy worth $171k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $171k of MDLN on Jun 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Jessi L Corcoran's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jessi L Corcoran has 0.
Where does Jessi L Corcoran file Form 4?
Jessi L Corcoran has filed Form 4 at MDLN (Medline Inc.) as Principal Accounting Officer; JBTM (John Bean Technologies CORP) as VP, Corporate Controller & CAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.